The co-expression and interaction of CEBPB and STAT3 may enhance oncogenic processes in ccRCC, contributing to its aggressive nature by shaping the tumor microenvironment through immune cell recruitment and activation [17,18]. Here, CEBPB is linked to nonpapillary renal cell carcinoma.